Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 2/2021

22.01.2021 | COVID-19 | Tropical, Travel and Emerging Infections (L Chen and A Boggild, Section Editors) Zur Zeit gratis

What Is the Impact of Lockdowns on Dengue?

verfasst von: Oliver Brady, Annelies Wilder-Smith

Erschienen in: Current Infectious Disease Reports | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Societal lockdowns in response to the COVID-19 pandemic have led to unprecedented disruption to daily life across the globe. A collateral effect of these lockdowns may be a change to transmission dynamics of a wide range of infectious diseases that are all highly dependent on rates of contact between humans. With timing, duration and intensity of lockdowns varying country-to-country, the wave of lockdowns in 2020 present a unique opportunity to observe how changes in human contact rates, disease control and surveillance affect dengue virus transmission in a global natural experiment. We explore the theoretical basis for the impact of lockdowns on dengue transmission and surveillance then summarise the current evidence base from country reports.

Recent Findings

We find considerable variation in the intensity of dengue epidemics reported so far in 2020 with some countries experiencing historic low levels of transmission while others are seeing record outbreaks. Despite many studies warning of the risks of lockdown for dengue transmission, few empirically quantify the impact and issues such as the specific timing of the lockdowns and multi-annual cycles of dengue are not accounted for. In the few studies where such issues have been accounted for, the impact of lockdowns on dengue appears to be limited.

Summary

Studying the impact of lockdowns on dengue transmission is important both in how we deal with the immediate COVID-19 and dengue crisis, but also over the coming years in the post-pandemic recovery period. It is clear lockdowns have had very different impacts in different settings. Further analyses might ultimately allow this unique natural experiment to provide insights into how to better control dengue that will ultimately lead to better long-term control.
Literatur
1.
Wilder-Smith A, Bar-Yam Y, Fisher D. Lockdown to contain COVID-19 is a window of opportunity to prevent the second wave. J Travel Med. 2020;27(5):8-20.
2.
Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020.
3.
Pachetti M, Marini B, Giudici F, Benedetti F, Angeletti S, Ciccozzi M, et al. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America. J Transl Med. 2020;18(1):338.PubMedPubMedCentralCrossRef
4.
Zheng Q, Jones FK, Leavitt SV, Ung L, Labrique AB, Peters DH, et al. HIT-COVID, a global database tracking public health interventions to COVID-19. Sci Data. 2020;7(1):286.PubMedPubMedCentralCrossRef
5.
Chu IY, Alam P, Larson H, Lin L. Social consequences of mass quarantine during epidemics: a systematic review with implications for the COVID-19 response. J Travel Med 2020.
6.
Chan CP, Wong NS, Leung CC, Lee SS. Positive impact of measures against COVID-19 on reducing influenza in the northern hemisphere. J Travel Med. 2020.
7.
Sun J, Shi Z, Xu H. Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020. J Travel Med. 2020.
8.•
Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–e88 This paper highlights the positive impact of lockdowns on reducing influenza.PubMedPubMedCentralCrossRef
9.
Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–9.PubMedPubMedCentralCrossRef
10.
Leong WY. Measles cases hit record high in Europe in 2018. J Travel Med. 2018;25(1).
11.
Massad E. Measles and human movement in Europe. J Travel Med. 2018;25(1).
12.
13.
Nicolay N, Mirinaviciute G, Mollet T, Celentano LP, Bacci S. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020. Euro Surveill. 2020;25(31).
14.
Chen CH, Lai CC, Chao CM, Tang HJ. Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19. J Inf Secur 2020.
15.
de Swart RL, Takeda M. Editorial overview: combating measles during a COVID-19 pandemic. Curr Opin Virol. 2020;41:iii–vii.PubMedCrossRef
16.
Wu D, Liu Q, Wu T, Wang D, Lu J. The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China. Immun Inflamm Dis. 2020
17.
Steffen R, Lautenschlager S, Fehr J. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. J Travel Med. 2020.
18.
de Miguel Buckley R, Trigo E, de la Calle-Prieto F, Arsuaga M, Diaz-Menendez M. Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. J Travel Med. 2020.
19.••
Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019;393(10169):350–63 A review article that summarises all the state-of-art in dengue related to pathophysiology, clinical management and epidemiology.PubMedCrossRef
20.
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7.PubMedPubMedCentralCrossRef
21.••
Halstead S, Wilder-Smith A. Severe dengue in travellers: pathogenesis, risk and clinical management. J Travel Med. 2019;26(7):taz062 Very thorough review on the epidemiology of dengue in travelers including discussions on risk of severe dengue and risk factors.PubMedCrossRef
22.•
Redondo-Bravo L, Ruiz-Huerta C, Gomez-Barroso D, Sierra-Moros MJ, Benito A, Herrador Z. Imported dengue in Spain: a nationwide analysis with predictive time series analyses. J Travel Med. 2019;26(8):taz072 Modelling study that shows the increasing trend of imported dengue.PubMedPubMedCentralCrossRef
23.
Rowe SL, Thevarajan I, Richards J, Gibney K, Simmons CP. The rise of imported dengue infections in Victoria, Australia, 2010(−)2016. Trop Med Infect Dis. 2018;3(1):9.PubMedCentralCrossRef
24.
Masyeni S, Yohan B, Somia IKA, Myint KSA, Sasmono RT. Dengue infection in international travellers visiting Bali, Indonesia. J Travel Med. 2018;25(1):tay061.PubMedCentralCrossRef
25.
Riddell A, Babiker ZO. Imported dengue fever in East London: a 6-year retrospective observational study. J Travel Med. 2017;24(3):tax015.CrossRef
26.
Griffiths KM, Savini H, Brouqui P, Simon F, Parola P, Gautret P. Surveillance of travel-associated diseases at two referral centres in Marseille, France: a 12-year survey. J Travel Med. 2018;25(1):tay007.CrossRef
27.
Jentes ES, Lash RR, Johansson MA, Sharp TM, Henry R, Brady OJ, et al. Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians. J Travel Med. 2016;23(6):taw062.PubMedPubMedCentralCrossRef
28.
Struchiner CJ, Rocklov J, Wilder-Smith A, Massad E. Increasing dengue incidence in Singapore over the past 40 years: population growth, Climate and Mobility. PLoS One. 2015;10(8):e0136286.PubMedPubMedCentralCrossRef
29.
30.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.PubMedPubMedCentralCrossRef
31.
Lye DC, Lee VJ, Sun Y, Leo YS. The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis. 2010;14(5):e410–3.PubMedCrossRef
32.
Kuo HJ, Lee IK, Liu JW. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: emphasizing risk of severe dengue in the elderly. J Microbiol Immunol Infect. 2018;51(6):740–8.PubMedCrossRef
33.
L’Azou M, Moureau A, Sarti E, Nealon J, Zambrano B, Wartel TA, et al. Symptomatic dengue in children in 10 Asian and Latin American countries. N Engl J Med. 2016;374(12):1155–66.PubMedCrossRef
34.
Dengue: guidelines for diagnosis, treatment, prevention and control. Organization WH. Geneva: World Health Organization; 2009.
35.
Wilder-Smith A. Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers. J Travel Med. 2018;25(1):tay057.
36.
Hunsperger E, Peeling R, Gubler DJ, Ooi EE. Dengue pre-vaccination serology screening for the use of Dengvaxia(R). J Travel Med. 2019;26(8):taz092.PubMedCrossRef
37.
Bonaparte M, Zheng L, Garg S, Guy B, Lustig Y, Schwartz E, et al. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection. J Travel Med. 2019;26(8):taz078.PubMedCrossRef
38.
Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.PubMedPubMedCentralCrossRef
39.
Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
40.
Brady OJ, Hay SI. The global expansion of dengue: how Aedes aegypti mosquitoes enabled the first pandemic Arbovirus. Annu Rev Entomol. 2020;65:191–208.PubMedCrossRef
41.
Yan G, Lee CK, Lam LTM, Yan B, Chua YX, Lim AYN, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;20:536.PubMedPubMedCentralCrossRef
42.
Wilder-Smith A, Tissera H, Ooi EE, Coloma J, Scott TW, Gubler DJ. Preventing dengue epidemics during the COVID-19 pandemic. Am J Trop Med Hyg. 2020;103(2):570–1.PubMedPubMedCentralCrossRef
43.
Yi H, Ng ST, Farwin A, Low PTA, Chang CM, Lim J. Health equity considerations in COVID-19: geospatial network analysis of the COVID-19 outbreak in the migrant population in Singapore. J Travel Med. 2020;2020:taaa159.
44.
de Souza CDF, do Carmo RF, Machado MF. The burden of COVID-19 in Brazil is greater in areas with high social deprivation. J Travel Med. 2020;27:taaa145.PubMedCrossRef
45.
Da Conceicao Araujo D, Dos Santos AD, Lima S, Vaez AC, Cunha JO, de Araújo KCGM. Determining the association between dengue and social inequality factors in north-eastern Brazil: a spatial modelling. Geospat Health. 2020;15(1).
46.
Torres JR, Castro JS. Venezuela’s migration crisis: a growing health threat to the region requiring immediate attention. J Travel Med. 2019;26(2):tay141.PubMedCrossRef
47.
Tuite AR, Thomas-Bachli A, Acosta H, Bhatia D, Huber C, Petrasek K, et al. Infectious disease implications of large-scale migration of Venezuelan nationals. J Travel Med. 2018;25(1):tay077.PubMedCentral
48.
Rodriguez-Morales AJ, Bonilla-Aldana DK, Bonilla-Aldana JC, Mondragon-Cardona A. Arboviral diseases among internally displaced people of Neiva, Colombia, 2015–2017. J Travel Med. 2019;26(2):tay162.PubMedCrossRef
49.
50.
Dureab F, Muller O, Jahn A. Resurgence of diphtheria in Yemen due to population movement. J Travel Med. 2018;25(1).
51.
Brady OJ, Godfray HC, Tatem AJ, Gething PW, Cohen JM, McKenzie FE, et al. Vectorial capacity and vector control: reconsidering sensitivity to parameters for malaria elimination. Trans R Soc Trop Med Hyg. 2016;110(2):107–17.PubMedPubMedCentralCrossRef
52.••
Daniel Reegan A, Rajiv Gandhi M, Cruz Asharaja A, Devi C, Shanthakumar SP. COVID-19 lockdown: impact assessment on Aedes larval indices, breeding habitats, effects on vector control programme and prevention of dengue outbreaks. Heliyon. 2020;6(10):e05181 Assessment relevant to our primary question whether lockdowns impact dengue incidence.PubMedPubMedCentralCrossRef
53.
Guzzetta G, Marques-Toledo CA, Rosa R, Teixeira M, Merler S. Quantifying the spatial spread of dengue in a non-endemic Brazilian metropolis via transmission chain reconstruction. Nat Commun. 2018;9(1):2837.PubMedPubMedCentralCrossRef
54.
Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008;92(6):1377–90 x.PubMedCrossRef
55.
Stoddard ST, Forshey BM, Morrison AC, Paz-Soldan VA, Vazquez-Prokopec GM, Astete H, et al. House-to-house human movement drives dengue virus transmission. Proc Natl Acad Sci U S A. 2013;110(3):994–9.PubMedCrossRef
56.
Reiner RC Jr, Stoddard ST, Scott TW. Socially structured human movement shapes dengue transmission despite the diffusive effect of mosquito dispersal. Epidemics. 2014;6:30–6.PubMedPubMedCentralCrossRef
57.
Salje H, Lessler J, Maljkovic Berry I, Melendrez MC, Endy T, Kalayanarooj S, et al. Dengue diversity across spatial and temporal scales: local structure and the effect of host population size. Science. 2017;355(6331):1302–6.PubMedPubMedCentralCrossRef
58.
Wesolowski A, Qureshi T, Boni MF, Sundsoy PR, Johansson MA, Rasheed SB, et al. Impact of human mobility on the emergence of dengue epidemics in Pakistan. Proc Natl Acad Sci U S A. 2015;112(38):11887–92.PubMedPubMedCentralCrossRef
59.
Tian H, Sun Z, Faria NR, Yang J, Cazelles B, Huang S, et al. Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia. PLoS Negl Trop Dis. 2017;11(8):e0005694.PubMedPubMedCentralCrossRef
60.
Ma Y, Li S, Wan Z, Huang X, Jin X, Tian Z, et al. Phylogenetic analyses of dengue virus serotypes imported to Shanghai, China. J Travel Med. 2020;27(7):taaa195.PubMedCrossRef
61.
Hautz WE, Sauter TC, Exadakytlos AK, Krummrey G, Schauber S, Muller M. Barriers to seeking emergency care during the COVID-19 pandemic may lead to higher morbidity and mortality-a retrospective study from a Swiss university hospital. Swiss Med Wkly. 2020;150:w20331.PubMed
62.
Lillepold K, Rocklov J, Liu-Helmersson J, Sewe M, Semenza JC. More arboviral disease outbreaks in continental Europe due to the warming climate? J Travel Med. 2019;26(5):taz017.PubMedCrossRef
63.
Rocklov J, Quam MB, Sudre B, German M, Kraemer MUG, Brady O, et al. Assessing seasonal risks for the introduction and mosquito-borne spread of Zika virus in Europe. EBioMedicine. 2016;9:250–6.PubMedPubMedCentralCrossRef
64.•
Semenza JC, Ebi KL. Climate change impact on migration, travel, travel destinations and the tourism industry. J Travel Med. 2019;26(5):taz026 Extensive review on climate change and its impact on dengue and other infectious diseases.PubMedCrossRef
65.
Vilcassim MJR, Thurston GD, Chen LC, Lim CC, Saunders E, Yao Y, et al. Exposure to air pollution is associated with adverse cardiopulmonary health effects in international travellers. J Travel Med. 2019;26(5):taz032.PubMedPubMedCentralCrossRef
66.
Hormann S, Jammoul F, Kuenzer T, Stadlober E. Separating the impact of gradual lockdown measures on air pollutants from seasonal variability. Atmos Pollut Res. 2020.
67.•
Madewell ZJ, Lopez MR, Espinosa-Bode A, Brouwer KC, Sanchez CG, McCracken JP. Inverse association between dengue, chikungunya, and Zika virus infection and indicators of household air pollution in Santa Rosa, Guatemala: a case-control study, 2011–2018. PLoS One. 2020;15(6):e0234399 First thorough study to show the relationship between air pollution and dengue.PubMedPubMedCentralCrossRef
68.
Chowdhury PB, Hossain S, Biswas RK. A combination of COVID-19 and dengue fever in Bangladesh: preparedness of Bangladesh. J Glob Health. 2020;10(2):020314.PubMedPubMedCentralCrossRef
69.
Poveda G. Concomitant malaria, dengue and COVID-19: an extraordinary challenge for Colombia’s public health system. Curr Opin Environ Sustain 2020.
70.
Miah MA, Husna A. Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: a serious health concern. J Med Virol 2020.
71.
Lorenz C, Azevedo TS, Chiaravalloti-Neto F. COVID-19 and dengue fever: a dangerous combination for the health system in Brazil. Travel Med Infect Dis. 2020;35:101659.PubMedPubMedCentralCrossRef
72.
Rana MS, Alam MM, Ikram A, Zaidi SSZ, Salman M, Khurshid A. Cocirculation of COVID-19 and dengue: a perspective from Pakistan. J Med Virol 2020.
73.
Vasquez-Chavesta AZ, Moran-Marinos C, Rodrigo-Gallardo PK, Toro-Huamanchumo CJ. COVID-19 and dengue: pushing the peruvian health care system over the edge. Travel Med Infect Dis. 2020;36:101808.PubMedPubMedCentralCrossRef
74.
Lam LTM, Chua YX, Tan DHY. Roles and challenges of primary care physicians facing a dual outbreak of COVID-19 and dengue in Singapore. Fam Pract. 2020;37(4):578–9.PubMedCrossRef
75.••
Lim JT, Dickens BS, Chew LZX, Choo ELW, Koo JR, Aik J, et al. Impact of sars-cov-2 interventions on dengue transmission. PLoS Negl Trop Dis. 2020;14(10):e0008719 Study to examine how lockdown for COVID-19 led to an increase of dengue in Singapore.PubMedPubMedCentralCrossRef
76.
Navarro JC, Arrivillaga-Henriquez J, Salazar-Loor J, Rodriguez-Morales AJ. COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: pushing strained health care systems over the edge. Travel Med Infect Dis. 2020;37:101656.PubMedPubMedCentralCrossRef
77.
78.
Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Mendez CA, Zambrano LI, Franco-Paredes C, et al. COVID-19 in Latin America: the implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020;35:101613.PubMedPubMedCentralCrossRef
79.
Lin SF, Lai CC, Chao CM, Tang HJ. Impact of COVID-19 preventative measures on dengue infections in Taiwan. J Med Virol. 2020.
80.
81.••
Mascarenhas MDM, Batista FMA, Rodrigues MTP, Barbosa OAA, Barros VC. Simultaneous occurrence of COVID-19 and dengue: what do the data show? Cad Saude Publica. 2020;36(6):e00126520 A study showing the relationship between COVID-19 and its pandemic response and dengue incidence.PubMedCrossRef
82.
Tsheten T, Wangchuk S, Wangmo D, Clements ACA, Gray DJ, Wangdi K. COVID-19 response and lessons learned on dengue control in Bhutan. J Med Entomol 2020.
83.
Cardona-Ospina JA, Arteaga-Livias K, Villamil-Gomez WE, Perez-Diaz CE, Katterine Bonilla-Aldana D, Mondragon-Cardona A, et al. Dengue and COVID-19, overlapping epidemics? An analysis from Colombia. J Med Virol 2020.
84.
85.
Anders KL, le Nga H, Thuy NT, Ngoc TV, Tam CT, Tai LT, et al. Households as foci for dengue transmission in highly urban Vietnam. PLoS Negl Trop Dis. 2015;9(2):e0003528.PubMedPubMedCentralCrossRef
86.
Bowman LR, Donegan S, McCall PJ. Is dengue vector control deficient in effectiveness or evidence?: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10(3):e0004551.PubMedPubMedCentralCrossRef
87.
Jarvis CI, Van Zandvoort K, Gimma A, Prem K, group CC-w, Klepac P, et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020;18(1):124.PubMedPubMedCentralCrossRef
88.
Neumayr A, Munoz J, Schunk M, Bottieau E, Cramer J, Calleri G, et al. Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research Initiative. Euro Surveill 2017;22(1).
89.
Wilder-Smith A, Boggild AK. Sentinel surveillance in travel medicine: 20 years of GeoSentinel publications (1999–2018). J Travel Med. 2018;25(1).
90.
Leder K, Torresi J, Brownstein JS, Wilson ME, Keystone JS, Barnett E, et al. Travel-associated illness trends and clusters, 2000-2010. Emerg Infect Dis. 2013;19(7):1049–73.PubMedPubMedCentralCrossRef
91.
Glaesser D, Kester J, Paulose H, Alizadeh A, Valentin B. Global travel patterns: an overview. J Travel Med. 2017;24(4).
92.
Angelo KM, Stoney RJ, Brun-Cottan G, Leder K, Grobusch MP, Hochberg N, et al. Zika among international travellers presenting to GeoSentinel sites, 2012–2019: implications for clinical practice. J Travel Med. 2020;27(4).
93.
Wilder-Smith A, Chang CR, Leong WY. Zika in travellers 1947–2017: a systematic review. J Travel Med. 2018;25(1).
94.
Angelo KM, Libman M, Gautret P, Barnett E, Grobusch MP, Hagmann SHF, et al. The rise in travel-associated measles infections-GeoSentinel, 2015–2019. J Travel Med. 2019;26(6).
95.
Boggild AK, Caumes E, Grobusch MP, Schwartz E, Hynes NA, Libman M, et al. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis. J Travel Med. 2019;26(8).
96.
Angelo KM, Libman M, Caumes E, Hamer DH, Kain KC, Leder K, et al. Malaria after international travel: a GeoSentinel analysis, 2003-2016. Malar J. 2017;16(1):293.PubMedPubMedCentralCrossRef
97.
Salzer HJF, Stoney RJ, Angelo KM, Rolling T, Grobusch MP, Libman M, et al. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017. J Travel Med. 2018;25(1).
98.
Boggild AK, Geduld J, Libman M, Yansouni CP, McCarthy AE, Hajek J, et al. Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet. J Travel Med. 2019;26(2).
99.
McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C, et al. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis. 2013;56(7):925–33.PubMedCrossRef
100.
Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, von Sonnenburg F, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43(9):1185–93.PubMedCrossRef
101.
Chen LH, Leder K, Barbre KA, Schlagenhauf P, Libman M, Keystone J, et al. Business travel-associated illness: a GeoSentinel analysis. J Travel Med. 2018;25(1).
102.
Angelo KM, Haulman NJ, Terry AC, Leung DT, Chen LH, Barnett ED, et al. Illness among US resident student travellers after return to the USA: a GeoSentinel analysis, 2007–17. J Travel Med. 2018;25(1).
103.
Schwartz E, Weld LH, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain KC, et al. Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006. Emerg Infect Dis. 2008;14(7):1081–8.PubMedPubMedCentralCrossRef
104.
Schwartz E, Meltzer E, Mendelson M, Tooke A, Steiner F, Gautret P, et al. Detection on four continents of dengue fever cases related to an ongoing outbreak in Luanda, Angola, March to May 2013. Euro Surveill. 2013;18(21).
105.
Bogoch II, Brady OJ, Kraemer MUG, German M, Creatore MI, Kulkarni MA, et al. Anticipating the international spread of Zika virus from Brazil. Lancet. 2016;387(10016):335–6.PubMedPubMedCentralCrossRef
106.••
Massad E, Amaku M, FAB C, Struchiner CJ, Burattini MN, Khan K, et al. Estimating the probability of dengue virus introduction and secondary autochthonous cases in Europe. Sci Rep. 2018;8(1):4629 Modelling study that shows the low risk of dengue establishment in Europe.PubMedPubMedCentralCrossRef
107.
Angelo KM, Stoney RJ, Brun-Cottan G, Leder K, Grobusch MP, Hochberg N, Kuhn S, Bottieau E, Schlagenhauf P, Chen L, Hynes NA, Perez CP, Mockenhaupt FP, Molina I, Crespillo-Andújar C, Malvy D, Caumes E, Plourde P, Shaw M, McCarthy AE, Piper-Jenks N, Connor BA, Hamer DH, Wilder-Smith A Zika among international travelers presenting to GeoSentinel sites, 2012-2019: implications for clinical practice. J Travel Med. 2020;27(4):taaa061.
108.
Dickens BL, Koo JR, Lim JT, Sun H, Clapham HE, Wilder-Smith A, et al. Strategies at points of entry to reduce importation risk of COVID-19 cases and re-open travel. J Travel Med. 2020;27(8):taaa141.
109.
Banks SD, Murray N, Wilder-Smith A, Logan JG. Insecticide-treated clothes for the control of vector-borne diseases: a review on effectiveness and safety. Med Vet Entomol. 2014;28(Suppl 1):14–25.PubMedCrossRef
110.
Goodyer L, Schofield S. Mosquito repellents for the traveller: does picaridin provide longer protection than DEET? J Travel Med. 2018;25(suppl_1):S10–S5.PubMedCrossRef
Metadaten
Titel
What Is the Impact of Lockdowns on Dengue?
verfasst von
Oliver Brady
Annelies Wilder-Smith
Publikationsdatum
22.01.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Current Infectious Disease Reports / Ausgabe 2/2021
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-020-00744-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise